CD7 es una glicoproteína de membrana y el primer antígeno específico de linfocito T en expresarse. Asimismo, es también el único marcador temprano que perdura a lo largo de la diferenciación.

Se ha observado la expresión del antígeno CD7 en la mayoría de los linfocitos T de sangre periférica, linfocitos natural killer y timocitos.

Es útil en el diagnóstico diferencial entre linfoma de células T y linfoma de células B.

 

 

 

BIBLIOGRAFÍA

• National Committee for Clinical Laboratory Standards (NCCLS). Protection of laboratory workers from infectious diseases transmitted by blood and tissue; proposed guideline. Villanova, P.A. 1991; 7(9). Order code M29-P.
• Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. Progress in Surgical Pathology. 6:1–15. eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc., Philadelphia.
• Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Laboratory Medicine. 1983; 14:767.
• Omata M, Liew CT, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen: a possible source of error in immunohistochemistry. American Journal of Clinical Pathology. 1980; 73:626.
• Leong FJW-M and Leong AS-Y. Essential markers in malignant lymphoma: a diagnostic approach. The Journal of Histotechnology. 2002; 25(4):215-227.
• Ormsby A, Bergfeld WF, Tubbs RR et al. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. Journal of the American Academy of Dermatology. 2001; 45(3):405-413-

01-2015 / M.Verdú, Dra. R. Orellana